Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Eur J Heart Fail. 2017 Oct 8;19(12):1675–1685. doi: 10.1002/ejhf.913

Table 4.

Univariate predictors of V̇E/V̇CO2 slope

b (95% CL) β (95% CL) Intercept (95% CL) R2 (95% CL) P-value

HFrEF
D 33 (8, 59) 0.44 (0.11, 0.68) 29 (18, 41) 0.20 (−0.03, 0.43) 0.01
A 0.26 (−0.40, 0.92) 0.14 (−0.22, 0.47) 38 (24, 52) 0.02 (−0.07, 0.11) 0.43
PaO2 0.11 (−0.18, 0.40) 0.14 (−0.22, 0.47) 35 (12, 58) 0.02 (−0.07, 0.11) 0.45
PAO2 1.29 (0.89, 1.69) 0.77 (0.58, 0.88) −100 (−144, −55) 0.59 (0.39, 0.79) <0.001
PA-aO2 0.19 (−0.10, 0.49) 0.24 (−0.12, 0.54) 37 (26, 48) 0.06 (−0.09, 0.21) 0.19
DLO2 1.41 (−0.16, 2.99) 0.32 (−0.03, 0.60) 37 (29, 45) 0.10 (−0.08, 0.28) 0.08
PACO2 −1.37 (−1.87, −0.87) −0.72 (−0.85, −0.50) 90 (73, 107) 0.51 (0.28, 0.74) <0.001
HCO3 −1.70 (−2.64, −0.76) −0.56 (−0.76, −0.26) 79 (59, 100) 0.31 (0.06, 0.56) <0.01
Base excess −1.44 (−2.48, −0.40) −0.46 (−0.70, −0.13) 39 (34, 44) 0.21 (−0.02, 0.44) <0.01
HFpEF
D 31 (8, 53) 0.49 (0.14, 0.73) 25 (17, 32) 0.24 (−0.02, 0.50) <0.01
A 0.00 (−0.42, 0.44) 0.01 (−0.37, 0.39) 34 (25, 44) 0.00 (0.0, 0.0) 0.98
PaO2 −0.03 (−0.24, 0.18) −0.06 (−0.43, 0.33) 36 (21, 52) 0.00 (−0.04, 0.04) 0.77
PAO2 0.92 (0.38, 1.47) 0.57 (0.24, 0.78) −65 (−124, −7) 0.33 (0.06, 0.60) <0.01
PA-aO2 0.13 (−0.08, 0.35) 0.25 (−0.14, 0.58) 30 (22, 37) 0.06 (−0.10, 0.22) 0.21
DLO2 0.95 (−0.09, 1.98) 0.35 (−0.03, 0.64) 30 (25, 35) 0.13 (−0.09, 0.35) 0.07
PACO2 −0.80 (−1.40, −0.20) −0.48 (−0.73, −0.12) 64 (41, 86) 0.23 (−0.03, 0.49) 0.01
HCO3 −0.40 (−1.66, 0.87) −0.13 (−0.49, 0.26) 43 (15, 71) 0.02 (−0.08, 0.12) 0.53
Base excess −0.04 (−1.21, 1.12) −0.02 (−0.40, 0.36) 34 (30, 39) 0.00 (−0.01, 0.01) 0.94

Data are model parameters from univariate linear regressions predicting V̇E/V̇CO2 slope from rest to peak exercise in heart failure with reduced (HFrEF, N=32) or preserved (HFpEF, N=27) ejection fraction. Standardized beta (β). See definition of variables in Table 3 caption.